Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

COLY

Coley Pharmaceutical Grp. (MM) (COLY)

Coley Pharmaceutical Grp. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:COLY
DateTimeSourceHeadlineSymbolCompany
01/04/20085:35PMPR Newswire (US)QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer IndexNASDAQ:COLYColey Pharmaceutical Grp. (MM)
01/03/20082:58PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
12/31/20079:11AMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
12/31/20078:00AMBusiness WirePfizer Inc Announces Completion of the Tender Offer Relating to Outstanding Shares of Coley Pharmaceutical Group, Inc.NASDAQ:COLYColey Pharmaceutical Grp. (MM)
12/21/20074:13PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Statement of Beneficial Ownership (SC 13D)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
12/18/20078:32AMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
12/18/20078:00AMBusiness WirePfizer Inc Clears Antitrust Review for Acquisition of All Outstanding Shares of Coley Pharmaceutical Group, Inc.NASDAQ:COLYColey Pharmaceutical Grp. (MM)
12/14/20074:12PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Statement of Changes in Beneficial Ownership (4)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/30/20078:59AMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/30/20078:55AMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Tender offer statement by Third Party (SC TO-T)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/28/20076:04AMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/26/20071:29PMPR Newswire (US)Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare ConferenceNASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/20/20074:50PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Amended Current report filing (8-K/A)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/19/200712:58PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Amended Statement of Ownership (SC 13G/A)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/16/20074:15PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Current report filing (8-K)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/16/20072:30PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/16/200710:54AMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/16/20079:35AMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Written communication relating to an issuer or third party (SC TO-C)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
11/01/20074:05PMPR Newswire (US)Coley Pharmaceutical Group Reports Third Quarter and Nine-month Financial ResultsNASDAQ:COLYColey Pharmaceutical Grp. (MM)
10/31/20072:24PMPR Newswire (US)Coley Pharmaceutical Group to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare ConferenceNASDAQ:COLYColey Pharmaceutical Grp. (MM)
10/30/20079:00AMPR Newswire (US)Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical DevelopmentNASDAQ:COLYColey Pharmaceutical Grp. (MM)
10/29/20079:00AMPR Newswire (US)Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus ErythematNASDAQ:COLYColey Pharmaceutical Grp. (MM)
10/26/200711:34AMPR Newswire (US)Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKlineNASDAQ:COLYColey Pharmaceutical Grp. (MM)
10/25/20078:30AMPR Newswire (US)Coley Pharmaceutical Group to Report Third Quarter Results on November 1, 2007NASDAQ:COLYColey Pharmaceutical Grp. (MM)
10/09/20078:11AMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Securities Registration (section 12(b)) (8-A12B)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
10/09/20078:09AMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. - Current report filing (8-K)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
10/08/20078:30AMPR Newswire (US)Coley Pharmaceutical Group Adopts Shareholder Rights PlanNASDAQ:COLYColey Pharmaceutical Grp. (MM)
09/20/20073:18PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. (Other) (4)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
09/20/20073:18PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. (Other) (4)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
09/20/20073:17PMEdgar (US Regulatory)Coley Pharmaceutical Group, Inc. (Other) (4)NASDAQ:COLYColey Pharmaceutical Grp. (MM)
 Showing the most relevant articles for your search:NASDAQ:COLY